Hiprabovis IBR Marker Live (infectious bovine rhinotracheitis vaccine (live)) - Increase in the incidence of anaphylactic-type reactions in cattle
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Hiprabovis IBR Marker Live
|
| Active substance |
live gE- tk- double-gene-deleted bovine herpes virus type 1, strain CEDDEL: 106.3–107.3 CCID50
|
| Procedure number |
EMEA/V/C/000158
|
| Regulatory outcome |
Variation
|
| DHPC type |
Adverse event
|
| Veterinary ATC codes |
QI02AD01
|
| Species |
Cattle
|
| Dissemination date |
11/08/2022
|